Prostate cancer in black and white Americans

被引：0
作者：
Sreekanth Reddy
Marc Shapiro
Ronald Morton
Otis W. Brawley
机构：
[1] Emory University,Winship Cancer Institute
[2] Baylor School of Medicine,Department of Urology
来源：
Cancer and Metastasis Reviews | 2003年 / 22卷
关键词：
prostate cancer; race; genetics; outcomes; hormones;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The prostate cancer incidence and mortality of black Americans is among the highest in the world. The reasons have not been adequately explained. Similar disparities have been noted for men of sub-Saharan origin living in Brazil and the Caribbean. Avenues of investigation have assessed racial and ethnic differences in diet as well as possible differences in the prevalence of genetics (both polymorphisms and mutations). There are studies to suggest that there are no racial differences in outcome when there is equal treatment. Several studies show that there are racial differences in patterns of care in the US and it has been hypothesized that this contributes to some of the racial disparity in survival after diagnosis.
引用
收藏
页码：83 / 86
页数：3
相关论文
共 204 条
  • [1] Glover FEJ(1998)Familial study of prostate cancer in Jamaica Urology 52 441-443
  • [2] Coffey DS(1991)Ethnicity and cancer risk in Sao Paulo, Brazil Cancer Epidemiol Biomarkers Prev 1 21-27
  • [3] Douglas LL(1995)Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada J Natl Cancer Inst 87 652-661
  • [4] Russell H(1999)Dietary factors and risks for prostate cancer among blacks and whites in the United States Cancer Epidemiol Biomarkers Prev 8 25-34
  • [5] Cadigan M(1994)5-Alpha-reductase inhibition and prostate cancer prevention Cancer Epidemiol Biomarkers Prev 3 177-182
  • [6] Tulloch T(1995)Serum androgens and sex hormonebinding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada Cancer Epidemiol Biomarkers Prev 4 735-741
  • [7] Wedderburn K(2002)5 alpha-reductase 2 polymorphisms as risk factors in prostate cancer Pharmacogenetics 12 307-312
  • [8] Wan RL(2002)Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis Prostate 52 269-278
  • [9] Baker TD(2000)Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals J Natl Cancer Inst 92 2009-2017
  • [10] Walsh PC(2000)8pter-p23 deletion is associated with racial differences in prostate cancer outcome Clin Cancer Res 6 4647-4652
12345678910